Search

everythinglearnresearchcommunity

for

Search:↓

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Innovative methods are reducing animal testing and improving biomedical research.

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

One Ashwagandha extract may help protect cells with its antioxidant properties, while another could promote hair growth.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Early skin biopsy helps diagnose and manage severe skin conditions in babies.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Drugs can change hair growth and this is important because it can upset people.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Stopping S100A3 activity slows down hair growth in mice.

Blocking IL-17a can improve age-related smell loss in mice.

Early identification of lupus through skin signs and blood tests is crucial in India.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Minoxidil boosts hair growth by activating PGHS-1.